Research


June 14, 2023

UAMS Provides Look at Bone Disease Research for Arkansas Undergraduates

Linda Satter

Jesus Delgado-Calle, an assistant professor of physiology and cell biology at UAMS, discusses his research with undergraduates and his team.

Twenty-eight undergraduates from colleges across the state recently visited the University of Arkansas for Medical Sciences (UAMS) campus to learn about potential careers in bone disease research. The Arkansas-IDeA Network of Biomedical Research Excellence (INBRE) sponsored the event. The students gathered May 23 in the Active Learning Center in the UAMS Library, where they listened…


June 1, 2023

Six Early-Career UAMS Researchers Receive KL2 Scholar Awards

David Robinson

The 2023-2024 KL2 Scholars are (l-r, clockwise from top): Mary “Katy” Allison, Michail Mavros, Brian D. Piccolo, Megha Sharma, Ankita Shukla and Alicja Urbaniak.

Six early-career researchers have been selected to receive two years of funded translational research training and support in the UAMS Translational Research Institute (TRI) KL2 Mentored Research Career Development Scholar Awards Program. The promising junior faculty researchers were selected for the 2023-2024 program through a competitive application process. KL2 scholars receive two years of mentored…


May 24, 2023

UAMS-TRI Training Program Helps Postdocs Develop Entrepreneurial Spirit, Form Competition-Winning Pharmaceutical Startup

David Robinson

Megan Reed, Ph.D. (left), and Julia Tobacyk, Ph.D., formed the company Pediatrica Therapeutics.

Only two years ago, the idea of commercializing their future research discoveries was a novel concept for Julia Tobacyk, Ph.D., and Megan Reed, Ph.D. Today they can say they created a startup company as postdoctoral fellows in the Health Sciences Innovation and Entrepreneurship (HSIE) training program, which is the National Institutes of Health’s (NIH) National…


May 16, 2023

BioVentures Introduces New Leadership, Expanded Resources at Commercialization Retreat

David Robinson

UAMS Chancellor Cam Patterson, M.D., MBA, said having a great team is the key to success as an entrepreneur.

The first BioVentures Commercialization Retreat drew 65 attendees to a full-day of  presentations packed with helpful information and inspirational stories. The presenters included keynote speaker Kevin Sexton, M.D., president of BioVentures LLC, and UAMS Chancellor Cam Patterson, M.D., MBA, whose 2016 book, “Research to Revenue: A Practical Guide to University Start-Ups,” was available for free…


May 15, 2023

American Cancer Society Funds UAMS Study of ACA’s Impact on Breast Cancer Treatment

David Robinson

Chenghui Li, Ph.D., said findings from her study should provide important insights into how the Affordable Care Act has impacted racial disparities in breast cancer treatment.

LITTLE ROCK — An American Cancer Society grant will support a University of Arkansas for Medical Sciences (UAMS) study of the Affordable Care Act’s (ACA) influence on racial disparities in the use of a common, life-saving treatment for Arkansas breast cancer patients. The two-year, $222,000 grant is led by Chenghui Li, Ph.D., an associate professor…


May 2, 2023

UAMS Researchers Find Financial Burdens for Cancer Survivors Vary by Insurance Type

David Wise

Cancer Patient Looking Stressed

FAYETTEVILLE — Rural women cancer survivors are more likely to experience financial strain related to basic household needs rather than medical debt, according to researchers from the University of Arkansas for Medical Sciences (UAMS) Office of Community Health & Research. The study, “It was kind of a nightmare, it really was:” Financial Toxicity Among Rural…


May 1, 2023

UAMS, NIH Study Finds Consoling, Other Techniques Better Than Drug Therapies for Newborns with Opioid Withdrawal

David Robinson

UAMS’ Jessica Snowden, M.D., said the study’s findings provide the first strong evidence needed to help end hospitals’ widely varying treatments of Neonatal Opioid Withdrawal Syndrome.

LITTLE ROCK — A groundbreaking nationwide clinical trial in which the University of Arkansas for Medical Sciences (UAMS) played a key role has confirmed an effective way to wean newborns from opioid withdrawal symptoms that substantially reduces hospital stays and the traditional use of drug therapies. Using an “Eat, Sleep, Console” (ESC) care approach resulted…


March 30, 2023

UAMS Researcher Awarded $1.8 Million to Study Potential Treatments for Neurological Diseases

Linda Satter

UAMS research scientist Fang Zheng, Ph.D., recently received from The National Institutes of Health a $1.8 million grant to, to continue research that could lead to new treatments for epilepsy and other neurological diseases.

LITTLE ROCK — The National Institutes of Health (NIH) has awarded a $1.8 million grant to Fang Zheng, Ph.D., an associate professor of pharmacology and toxicology at the University of Arkansas for Medical Sciences (UAMS), to continue research that could lead to new treatments for epilepsy and other neurological diseases. The NIH’s National Institute of…


March 27, 2023

Student Research Day Continues to Grow with Inclusion of Northwest Campus

Andrew Vogler

Student Research Day

Graduate and professional students, postdoctoral researchers, medical staff and fellows presented their research at the University of Arkansas for Medical Sciences’ (UAMS) Student Research Day, a university-wide event hosted by the Division of Research and Innovation, Academic Affairs, the Graduate School, the Northwest Regional Campus and Academic Senate. This year’s event was the first in…


NIH, NSF Fund UAMS Study of Rapid Genomic Testing to Aid Treatment of Dangerous Antibiotic-Resistant Infections

David Robinson

Se-Ran Jun, Ph.D., hopes her research will lead to rapid, life-saving genomic information for doctors treating the most dangerous antibiotic-resistant infections.

LITTLE ROCK — Two national grants are helping researchers at the University of Arkansas for Medical Sciences (UAMS) toward their goal of providing rapid, life-saving genomic information to doctors treating the most dangerous antibiotic-resistant infections. The study began with a $50,000 pilot award from the UAMS Translational Research Institute, which was used to gather data…



Previous page Next page